Afficher la couverture 'Deprescribing cholinesterase inhibitors at the end of life #354 | LIAO, Pamela' en grand format
/5

0 avis

Deprescribing cholinesterase inhibitors at the end of life #354

Article

LIAO, Pamela | PERRI, Giulia-Anna

Cholinesterase inhibitors (CHEIs) are the most commonly prescribed agents to delay the progression of cognitive decline from dementia, Parkinson's disease, and other degenerative neurologic diseases. Yet, as dementia progresses, the effectiveness of CHEIs diminish while adverse effects can mount. Other Fast Facts addressed dementia's natural history (# 150) and tension points in medical decision making (# 84). This Fast Facts addresses deprescribing considerations for CHEIs.

http://dx.doi.org/10.1089/jpm.2018.0220

Voir la revue «JOURNAL OF PALLIATIVE MEDICINE, 21»

Autres numéros de la revue «JOURNAL OF PALLIATIVE MEDICINE»

Consulter en ligne

Suggestions

Du même auteur

Deprescribing cholinesterase inhibitors at th...

Article indépendant | LIAO, Pamela | JOURNAL OF PALLIATIVE MEDICINE | n°7 | vol.21

Cholinesterase inhibitors (CHEIs) are the most commonly prescribed agents to delay the progression of cognitive decline from dementia, Parkinson's disease, and other degenerative neurologic diseases. Yet, as dementia progresses, t...

Deprescribing cholinesterase inhibitors at th...

Article indépendant | LIAO, Pamela | JOURNAL OF PALLIATIVE MEDICINE | n°7 | vol.21

Cholinesterase inhibitors (CHEIs) are the most commonly prescribed agents to delay the progression of cognitive decline from dementia, Parkinson's disease, and other degenerative neurologic diseases. Yet, as dementia progresses, t...

Bleeding management in hospice care settings ...

Article indépendant | LIAO, Pamela | JOURNAL OF PALLIATIVE MEDICINE | n°12 | vol.20

Bleeding is a distressing, complex, and relatively common symptom in palliative care. It can present at many anatomical sites and vary in acuity and presentation. This Fast Fact provides an approach to managing noncatastrophic ble...

De la même série

Feasibility of a palliative care intervention...

Article | VERMA, Manisha | JOURNAL OF PALLIATIVE MEDICINE | n°3 | vol.36

Background: Patients with hepatocellular cancer (HCC) are at risk for poor quality of life (QoL) and high symptom burden, coupled with limited treatment options. Palliative care (PC) can play an important role in reducing the suff...

"You suffer from being interested" : a tribut...

Article | MILLER, Pringl | JOURNAL OF PALLIATIVE MEDICINE | n°12 | vol.31

I met Hank during my palliative medicine fellowship after his nurse Cynthia paged me to request a consult for existential suffering. When reviewing Hank's electronic medical record, it became evident he was dying and averse to spe...

Evaluating a pediatric palliative care electi...

Article | CRAWFORD, Claire | JOURNAL OF PALLIATIVE MEDICINE | n°1 | vol.27

Background: Hospice and palliative medicine is important in the education of pediatric residents. Little is known about if and how residents' learnings during a pediatric palliative care elective fulfill core competencies and Pedi...

Associations between measures of disability a...

Article | CHANG, Victoria A. | JOURNAL OF PALLIATIVE MEDICINE | n°1 | vol.27

Background: The modified Rankin Scale (mRS), which measures degree of disability in daily activities, is the most common outcome measure in stroke research. Quality of life (QoL), however, is impacted by factors other than disabil...

Preliminary findings of an adapted nurse-led ...

Article | LAYNE, Diana | JOURNAL OF PALLIATIVE MEDICINE | n°1 | vol.27

Context: Despite the increased number of people living with Alzheimer's disease and related dementias (PLWD), limited early palliative care interventions exist for this population. Adapting promising interventions for other progre...

Chargement des enrichissements...